Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
74.80
+1.12 (1.52%)
May 12, 2025, 4:00 PM - Market closed
Edwards Lifesciences (EW) Revenue by Segment
History
| Date | Transcatheter Aortic Valve Replacement | Surgical Structural Heard | Transcatheter Mitral and Tricuspid Therapies | Critical Care |
|---|---|---|---|---|
| Mar 31, 2025 | 4.14B | 966.10M | 394.40M | - |
| Dec 31, 2024 | 4.11B | 981.30M | 352.10M | - |
| Sep 30, 2024 | 4.05B | 1.02B | 303.00M | - |
| Jun 30, 2024 | 3.99B | 1.03B | 264.30M | - |
| Mar 31, 2024 | 3.94B | 1.02B | 228.90M | 957.50M |
| Dec 31, 2023 | 3.88B | 999.30M | 197.60M | 928.10M |
| Sep 30, 2023 | 3.77B | 975.20M | 173.10M | 902.60M |
| Jun 30, 2023 | 3.67B | 948.30M | 150.40M | 888.90M |
| Mar 31, 2023 | 3.58B | 920.50M | 130.70M | 864.80M |
| Dec 31, 2022 | 3.52B | 893.10M | 116.10M | 855.00M |
| Sep 30, 2022 | 3.52B | 890.30M | 109.90M | 841.60M |
| Jun 30, 2022 | 3.52B | 888.00M | 102.50M | 847.00M |
| Mar 31, 2022 | 3.51B | 896.90M | 96.70M | 851.40M |
| Dec 31, 2021 | 3.42B | 889.10M | 86.00M | 834.90M |
| Sep 30, 2021 | 3.33B | 872.00M | 73.80M | 821.50M |
| Jun 30, 2021 | 3.21B | 857.90M | 63.60M | 789.70M |
| Mar 31, 2021 | 2.91B | 781.40M | 47.60M | 738.40M |
| Dec 31, 2020 | 2.86B | 761.80M | 41.80M | 725.40M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.